NASDAQ: CAMP
Camp4 Therapeutics Corp Stock Ownership - Who owns Camp4 Therapeutics?

Insider buying vs selling

Have Camp4 Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
5am Partners VI LLC10% Owner2024-10-15909,090$11.00
$10.00MBuy
Ah Equity Partners Bio I LLC10% Owner2024-10-15545,454$11.00
$6.00MBuy
Ah Equity Partners Bio I LLC10% Owner2024-10-15181,818$11.00
$2.00MBuy
Enavate Sciences GP LLC10% Owner2024-10-151,363,636$11.00
$15.00MBuy
Amir NashatDirector2024-10-15909,090$11.00
$10.00MBuy
Northpond Ventures II GP LLC10% Owner2024-10-15763,636$11.00
$8.40MBuy
Polaris Management Co VII LLC10% Owner2024-10-15909,090$11.00
$10.00MBuy
Polaris Management Co VII LLC10% Owner2024-10-15909,090$11.00
$10.00MBuy
Polaris Management Co VII LLC10% Owner2024-10-15909,090$11.00
$10.00MBuy
Andrew J. SchwabDirector2024-10-15909,090$11.00
$10.00MBuy

1 of 1

CAMP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAMP insiders and whales buy or sell their stock.

CAMP Shareholders

What type of owners hold Camp4 Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Enavate Sciences GP LLC18.78%3,785,802$5.11MInstitution
Enavate Sciences GP LLC18.78%3,785,802$5.11MInsider
5am Partners VI LLC14.52%2,927,915$3.95MInsider
5am Venture Management LLC14.52%2,927,915$3.95MInstitution
Andrew J. Schwab13.02%2,625,145$3.54MInsider
Northpond Ventures II GP LLC11.10%2,238,244$3.02MInsider
Ah Capital Management LLC10.54%2,125,339$2.87MInstitution
Ah Equity Partners Bio I LLC10.54%2,125,339$2.87MInsider
Harbourvest Partners LLC6.31%1,271,948$1.72MInstitution
Polaris Partners GP X LLC4.51%909,090$1.23MInsider

1 of 3

CAMP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAMP42.49%57.51%Net Buying
ENLV13.26%60.25%
OSRH0.17%99.83%
RADX0.02%0.00%
COEP0.37%99.63%

Camp4 Therapeutics Stock Ownership FAQ

Who owns Camp4 Therapeutics?

Camp4 Therapeutics (NASDAQ: CAMP) is owned by 62.88% institutional shareholders, 85.10% Camp4 Therapeutics insiders, and 0.00% retail investors. Enavate Sciences GP LLC is the largest individual Camp4 Therapeutics shareholder, owning 3.79M shares representing 18.78% of the company. Enavate Sciences GP LLC's Camp4 Therapeutics shares are currently valued at $5.11M.

If you're new to stock investing, here's how to buy Camp4 Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.